It’s in the ‘Genes’: The Quest to Develop a Cure for Rare, Genetic Diseases

By Hui Cai, VP of Corporate Alliances at WuXi AppTec (@HuiCai2) “We always felt like gene therapy was coming back, and it sure did. This technology represented a great way for us to come together as a team again to deliver the promise of gene editing...

Next Generation Immuno-Oncology: Creating a New Pathway to ‘Eat’ Cancer – A Chat with Jonathan MacQuitty, CEO, Forty Seven

By Richard Soll, Senior Vice President, WuXi AppTec (@richsollwx) "Even though there has been a lot of work on the adaptive side, on the innate side, there’s much less being done, even though there are good reasons to think it will be – and we...

Building a Global ‘Bridge’ for Life Science Innovation

By Hui Cai, VP of Corporate Alliances at WuXi AppTec (@HuiCai2) As the globalization of healthcare expands, Frank Yu and his team at Ally Bridge Group continue to differentiate themselves in the market with strategic and fruitful investments, and by boosting growth for life science companies...

Placing ‘Early’ Bets in Biotech

By: Hui Cai, VP of Corporate Alliances at WuXi AppTec (@HuiCai2) We’re very compelled by entrepreneurs…. It’s really that combination of technology that you fall in love with and people who we want to work with that drives us. We’ve determined that we want to be...

A New Era of Genetics Research: Connecting the Global Autism Scientific Community – A Chat With Alan Packer, Senior Scientist, Simons Foundation Autism Research Initiative

By Edward Farmer, Vice President, WuXi NextCODE “It’s only by connecting this diverse body of researchers with each other, and with a wide range of datasets in each area, that we have any hope of having a real-world impact on the lives of individuals and...

SPOTLIGHT

STAY CONNECTED

Twitter LinkedIn 

WUXI NEWS

A Futuristic Biopharma Company Addressing Some of the World’s Biggest Health...

By Rich Soll, Senior Advisor, Strategic Initiatives at WuXi AppTec (@richsollwx) For the past few years, PureTech Health has been building a new R&D model for advancing breakthrough...